Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Dow
QuintilesIMS
Mallinckrodt
Cerilliant
Federal Trade Commission
Deloitte
US Army
UBS

Generated: August 22, 2017

DrugPatentWatch Database Preview

Dalteparin sodium - Generic Drug Details

« Back to Dashboard

What are the generic sources for dalteparin sodium and what is the scope of dalteparin sodium patent protection?

Dalteparin sodium
is the generic ingredient in one branded drug marketed by Pfizer Inc and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for dalteparin sodium. One supplier is listed for this compound.

Summary for Generic Name: dalteparin sodium

Tradenames:1
Patents:0
Applicants:1
NDAs:1
Drug Master File Entries: see list7
Suppliers / Packagers: see list1
Bulk Api Vendors: see list6
Clinical Trials: see list2,425
Patent Applications: see list1
Therapeutic Class:Blood Products/Modifiers/ Volume Expanders
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:dalteparin sodium at DailyMed

Pharmacology for Ingredient: dalteparin sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer Inc
FRAGMIN
dalteparin sodium
INJECTABLE;SUBCUTANEOUS020287-001Dec 22, 1994RXYesNo► Subscribe► Subscribe► Subscribe
Pfizer Inc
FRAGMIN
dalteparin sodium
INJECTABLE;SUBCUTANEOUS020287-011May 1, 2007RXYesNo► Subscribe► Subscribe► Subscribe
Pfizer Inc
FRAGMIN
dalteparin sodium
INJECTABLE;SUBCUTANEOUS020287-006Apr 4, 2002RXYesYes► Subscribe► Subscribe► Subscribe
Pfizer Inc
FRAGMIN
dalteparin sodium
INJECTABLE;SUBCUTANEOUS020287-005Apr 4, 2002RXYesNo► Subscribe► Subscribe► Subscribe
Pfizer Inc
FRAGMIN
dalteparin sodium
INJECTABLE;SUBCUTANEOUS020287-004Jan 30, 1998RXYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: dalteparin sodium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer Inc
FRAGMIN
dalteparin sodium
INJECTABLE;SUBCUTANEOUS020287-001Dec 22, 1994► Subscribe► Subscribe
Pfizer Inc
FRAGMIN
dalteparin sodium
INJECTABLE;SUBCUTANEOUS020287-004Jan 30, 1998► Subscribe► Subscribe
Pfizer Inc
FRAGMIN
dalteparin sodium
INJECTABLE;SUBCUTANEOUS020287-003Mar 18, 1996► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Chubb
Daiichi Sankyo
Johnson and Johnson
Moodys
Baxter
Healthtrust
Julphar
Boehringer Ingelheim
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot